Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BXC - US09624H2085 - Common Stock

61.43 USD
-0.18 (-0.29%)
Last: 12/31/2025, 8:04:00 PM
61.43 USD
0 (0%)
After Hours: 12/31/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 50 industry peers in the Trading Companies & Distributors industry. BXC has only an average score on both its financial health and profitability. BXC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BXC was profitable.
In the past year BXC had a positive cash flow from operations.
BXC had positive earnings in each of the past 5 years.
Each year in the past 5 years BXC had a positive operating cash flow.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

BXC has a worse Return On Assets (0.89%) than 64.00% of its industry peers.
The Return On Equity of BXC (2.25%) is worse than 64.00% of its industry peers.
BXC has a Return On Invested Capital of 2.26%. This is in the lower half of the industry: BXC underperforms 68.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BXC is in line with the industry average of 9.63%.
The 3 year average ROIC (11.49%) for BXC is well above the current ROIC(2.26%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.89%
ROE 2.25%
ROIC 2.26%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

The Profit Margin of BXC (0.48%) is worse than 64.00% of its industry peers.
BXC's Profit Margin has declined in the last couple of years.
BXC has a worse Operating Margin (1.53%) than 70.00% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 15.34%, BXC is doing worse than 86.00% of the companies in the same industry.
BXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.53%
PM (TTM) 0.48%
GM 15.34%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BXC is still creating some value.
BXC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BXC has been reduced compared to 5 years ago.
Compared to 1 year ago, BXC has an improved debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.38 indicates that BXC is not in any danger for bankruptcy at the moment.
BXC has a Altman-Z score (3.38) which is in line with its industry peers.
A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
BXC has a worse Debt to Equity ratio (0.96) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.38
ROIC/WACC0.24
WACC9.32%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.60. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BXC (4.60) is better than 92.00% of its industry peers.
A Quick Ratio of 3.15 indicates that BXC has no problem at all paying its short term obligations.
BXC has a Quick ratio of 3.15. This is amongst the best in the industry. BXC outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 3.15
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -76.69% in the last year.
BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.26% yearly.
BXC shows a decrease in Revenue. In the last year, the revenue decreased by -0.19%.
Measured over the past years, BXC shows a small growth in Revenue. The Revenue has been growing by 2.28% on average per year.
EPS 1Y (TTM)-76.69%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-76.92%
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%0.21%

3.2 Future

BXC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.11% yearly.
BXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.48% yearly.
EPS Next Y-83.77%
EPS Next 2Y-45.45%
EPS Next 3Y-22.11%
EPS Next 5YN/A
Revenue Next Year-0.03%
Revenue Next 2Y1.5%
Revenue Next 3Y3.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.26 indicates a quite expensive valuation of BXC.
Compared to the rest of the industry, the Price/Earnings ratio of BXC is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.51, BXC is valued at the same level.
The Price/Forward Earnings ratio is 32.35, which means the current valuation is very expensive for BXC.
Based on the Price/Forward Earnings ratio, BXC is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
BXC is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.26
Fwd PE 32.35
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BXC is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.06
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -22.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.45%
EPS Next 3Y-22.11%

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BLUELINX HOLDINGS INC

NYSE:BXC (12/31/2025, 8:04:00 PM)

After market: 61.43 0 (0%)

61.43

-0.18 (-0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners99.25%
Inst Owner Change-4.31%
Ins Owners2.22%
Ins Owner Change0.13%
Market Cap483.45M
Revenue(TTM)2.95B
Net Income(TTM)14.04M
Analysts77.5
Price Target78.03 (27.02%)
Short Float %6.58%
Short Ratio5.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.92%
Min EPS beat(2)-24.67%
Max EPS beat(2)-23.18%
EPS beat(4)2
Avg EPS beat(4)-7.71%
Min EPS beat(4)-24.67%
Max EPS beat(4)16.15%
EPS beat(8)5
Avg EPS beat(8)19.7%
EPS beat(12)7
Avg EPS beat(12)12.15%
EPS beat(16)11
Avg EPS beat(16)19.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.77%
Revenue beat(12)2
Avg Revenue beat(12)-3.86%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)0%
PT rev (3m)-6.71%
EPS NQ rev (1m)-3.05%
EPS NQ rev (3m)-704.76%
EPS NY rev (1m)-28.45%
EPS NY rev (3m)-30.74%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-3.48%
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 30.26
Fwd PE 32.35
P/S 0.16
P/FCF N/A
P/OCF 28.96
P/B 0.78
P/tB 0.89
EV/EBITDA 8.06
EPS(TTM)2.03
EY3.3%
EPS(NY)1.9
Fwd EY3.09%
FCF(TTM)-3.19
FCFYN/A
OCF(TTM)2.12
OCFY3.45%
SpS374.69
BVpS79.16
TBVpS69.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.13
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 2.25%
ROCE 3.36%
ROIC 2.26%
ROICexc 3.32%
ROICexgc 3.63%
OM 1.53%
PM (TTM) 0.48%
GM 15.34%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexgc growth 3Y-37.08%
ROICexgc growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score6
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 7.16
Cap/Depr 108.51%
Cap/Sales 1.42%
Interest Coverage 0.97
Cash Conversion 19.98%
Profit Quality N/A
Current Ratio 4.6
Quick Ratio 3.15
Altman-Z 3.38
F-Score6
WACC9.32%
ROIC/WACC0.24
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-76.69%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-76.92%
EPS Next Y-83.77%
EPS Next 2Y-45.45%
EPS Next 3Y-22.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%0.21%
Revenue Next Year-0.03%
Revenue Next 2Y1.5%
Revenue Next 3Y3.48%
Revenue Next 5YN/A
EBIT growth 1Y-56.32%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-8.46%
EBIT Next 3Y8.68%
EBIT Next 5YN/A
FCF growth 1Y-107.18%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.66%
OCF growth 3Y-16.25%
OCF growth 5YN/A

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 1 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 4 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.